42.85MMarket Cap-7302P/E (TTM)
5.500High5.260Low9.20KVolume5.260Open5.270Pre Close50.38KTurnover0.16%Turnover RatioLossP/E (Static)7.82MShares6.05052wk High1.71P/B31.19MFloat Cap4.34052wk Low--Dividend TTM5.70MShs Float13.200Historical High--Div YieldTTM4.55%Amplitude1.000Historical Low5.477Avg Price1Lot Size
ImmuCell Stock Forum
ImmuCell Corporation (Nasdaq: ICCC), a key player in the animal health industry, has recently announced its preliminary, unaudited sales results for the first quarter of 2024, and the figures are nothing short of impressive. With a staggering 111% increase in sales compared to the same period in 2023, and a 42% increase from the last quarter of ...
No comment yet